that's a very sciencey answer but I was proposing more from a business strategy perspective
Business acumen and strategy has been offered up as one of ANP's and bio's weaknesses
But
There is a example pretty close to us of how to 'put on a clinic in execution and get stuff done' and display amazing commercial acumen with what you have and gain shareholder wealth
A little old company who has a crappy drug that doesn't really work has a market cap of $13 b and it called Sarepta
ANP with a potential platform drug that is apparently showing promise is worth $50m (i've heard it's drug is the best)
There should be one company we should be standing up and applauding it's amazing achievement to get to where it is with what it has (a little hint it is not ANP)
I am hopeful this company moves from a 'university research facility' to a 'commercial business model' at some stage, because the magic drug does not help fix anyone but mice and monkeys at the moment
There is much more to making a dollar or satisfying a market need than just having the best product, that is a start but a lot of other skill sets turn the best product into dollars in the bank and satisfied customers
- Forums
- ASX - By Stock
- PER
- Sarepta FDA Hearing
Sarepta FDA Hearing, page-76
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.001(1.27%) |
Mkt cap ! $82.94M |
Open | High | Low | Value | Volume |
8.0¢ | 8.3¢ | 7.9¢ | $461.5K | 5.711M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 844186 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 292500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 844186 | 0.080 |
8 | 506274 | 0.079 |
5 | 575000 | 0.078 |
8 | 1027327 | 0.077 |
4 | 346421 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 292500 | 1 |
0.083 | 30000 | 1 |
0.084 | 93750 | 1 |
0.085 | 187500 | 2 |
0.086 | 250000 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online